Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mercer

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Research in Microbiology|October 1, 1993
Novel bioactive compounds from actinomycetesJ J Sanglier, E M Wellington, V Behal, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics RegisterJ B Galloway, K L Hyrich, L K Mercer, et al.
Annals of the Rheumatic Diseases|January 14, 2012
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics RegisterLouise K Mercer, Adele C Green, James B Galloway, et al.
Rheumatology (Oxford, England)|August 3, 2010
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyJames B Galloway, Kimme L Hyrich, Louise K Mercer, et al.
Annals of the Rheumatic Diseases|August 10, 2016
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLouise K Mercer, James B Galloway, Mark Lunt, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterJames B Galloway, Louise K Mercer, Alison Moseley, et al.
Journal of Cell Science|February 10, 2006
Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranesHeli Ruotsalainen, Laura Sipilä, Miia Vapola, et al.
American Journal of Surgery|February 24, 2019
Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancyNeal Bhutiani, Seth A Quinn, Megan K Mercer, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 27, 2025
Nuclear Cerebrospinal Fluid Imaging: Guide to Procedures and InterpretationMegan K Mercer, Lisa C Blacklock, Jonathan W Revels, et al.
Infectious Diseases (London, England)|March 18, 2025
Molecular epidemiology and evolution of norovirus in Australia and New Zealand, 2018 to 2020Grace J H Yan, Joanne Hewitt, Lewis K Mercer, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Research in Microbiology|October 1, 1993
Novel bioactive compounds from actinomycetesJ J Sanglier, E M Wellington, V Behal, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics RegisterJ B Galloway, K L Hyrich, L K Mercer, et al.
Annals of the Rheumatic Diseases|January 14, 2012
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics RegisterLouise K Mercer, Adele C Green, James B Galloway, et al.
Rheumatology (Oxford, England)|August 3, 2010
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyJames B Galloway, Kimme L Hyrich, Louise K Mercer, et al.
Annals of the Rheumatic Diseases|August 10, 2016
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLouise K Mercer, James B Galloway, Mark Lunt, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterJames B Galloway, Louise K Mercer, Alison Moseley, et al.
Journal of Cell Science|February 10, 2006
Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranesHeli Ruotsalainen, Laura Sipilä, Miia Vapola, et al.
American Journal of Surgery|February 24, 2019
Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancyNeal Bhutiani, Seth A Quinn, Megan K Mercer, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 27, 2025
Nuclear Cerebrospinal Fluid Imaging: Guide to Procedures and InterpretationMegan K Mercer, Lisa C Blacklock, Jonathan W Revels, et al.
Infectious Diseases (London, England)|March 18, 2025
Molecular epidemiology and evolution of norovirus in Australia and New Zealand, 2018 to 2020Grace J H Yan, Joanne Hewitt, Lewis K Mercer, et al.
Pageof 10